Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT06365398
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT06365398
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06365398. Randomized; triple masking; primary purpose treatment. Start 2018-01-01 (actual); primary completion 2021-06-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy
- Acronym
- SELECT
- Condition
- Cerebral Angiography
- Condition
- Heparinization
- Intervention (Drug)
- Heparin
- Intervention (Drug)
- Heparin Sodium Injection
- Intervention (Other)
- No heparinization
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct06365398- Content hash
2ea75a131b562d1a3798618116fe358dc4504a7c4c55a9f7443788d28bc9840d